Cite
211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.
MLA
Frost, Sofia H. L., et al. “211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.” Journal of Nuclear Medicine, vol. 65, no. 8, Aug. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.2967/jnumed.124.267540.
APA
Frost, S. H. L., Orozco, J. J., Bäck, T. A., Miller, B. W., Santos, E. B., Kenoyer, A., Knoblaugh, S. E., Hamlin, D. K., Wilbur, D. S., & Sandmaier, B. M. (2024). 211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation. Journal of Nuclear Medicine, 65(8), 1–7. https://doi.org/10.2967/jnumed.124.267540
Chicago
Frost, Sofia H. L., Johnnie J. Orozco, Tom A. Bäck, Brian W. Miller, Erlinda B. Santos, Aimee Kenoyer, Sue E. Knoblaugh, Donald K. Hamlin, D. Scott Wilbur, and Brenda M. Sandmaier. 2024. “211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.” Journal of Nuclear Medicine 65 (8): 1–7. doi:10.2967/jnumed.124.267540.